| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
| Otitis Media | D010033 | 12 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Patamasucon P et al. | Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. | 1981 | Antimicrob. Agents Chemother. | pmid:6975059 |
| Simmen HP et al. | [Erythromycin]. | 1982 | Dtsch. Med. Wochenschr. | pmid:7117164 |
| Henry J et al. | Plasma and salivary concentrations of erythromycin after administration of three different formulations. | 1980 | Postgrad Med J | pmid:7220406 |
| Trujillo H | Cefadroxil monohydrate versus erythromycin in paediatric patients. | 1981 | J. Int. Med. Res. | pmid:7227625 |
| Abernathy CO et al. | Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note. | 1980 | Mech. Ageing Dev. | pmid:7354660 |
| Dujovne CA and Salhab AS | Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. | 1980 | Pharmacology | pmid:7403251 |
| DiSanto AR et al. | Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. | 1980 | J Clin Pharmacol | pmid:7430412 |
| Gilbert FI | Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962. | 1995 | Hawaii Med J | pmid:7642362 |
| Potthast H et al. | [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state]. | 1995 | Pharmazie | pmid:7886126 |
| Ginsburg CM et al. | Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions. | 1976 | J. Pediatr. | pmid:792404 |